| Basics |
|
GeoVax Labs, Inc.
|
| IPO Date: |
September 25, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$11.2M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 5.08%
|
| Avg Daily Range (30 D): |
$0.02 | 3.87%
|
| Avg Daily Range (90 D): |
$0.02 | 3.45%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.36M |
| Avg Daily Volume (30 D): |
.44M |
| Avg Daily Volume (90 D): |
.64M |
| Trade Size |
| Avg Trade Size (Sh.): |
309 |
| Avg Trade Size (Sh.) (30 D): |
347 |
| Avg Trade Size (Sh.) (90 D): |
415 |
| Institutional Trades |
| Total Inst.Trades: |
13 |
| Avg Inst. Trade: |
$.99M |
| Avg Inst. Trade (30 D): |
$.57M |
| Avg Inst. Trade (90 D): |
$.57M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.29M |
| Avg Closing Trade (30 D): |
$1.29M |
| Avg Closing Trade (90 D): |
$1.29M |
| Avg Closing Volume: |
154.64K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.41
|
$-.31
|
$-.35
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$ 3.35M
|
$ M
|
$ .85M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -25.31M
|
$ -6.32M
|
$ -5.37M
|
|
Operating Income / Loss
|
$ -25.54M
|
$ -6.37M
|
$ -5.42M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -3.58M
|
$ 1.92M
|
$ -4.34M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 31, 2024:
1:15
|
|
Sep 25, 2020:
1:20
|
|
Jan 24, 2020:
1:2000
|
|
May 02, 2019:
1:500
|
|
Apr 28, 2010:
1:50
|
|
|
|